Vanda Pharmaceuticals stock’s explosive rally may be more hype than substance
Vanda Pharmaceuticals (NASDAQ: VNDA) opened some 45% higher today after the biotech ...
In
Investing
Almirall profit quadruples in 2025 as dermatology fuels growth push
Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net ...
US stocks open flat after Trump raises global tariffs to 15%
US equities were little changed on Monday after President Donald Trump announced ...
Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push
Millions of people on GLP-1 weight-loss drugs know the weekly routine by ...
Royal Bank of Canada stock double-tops ahead of Q1 earnings
Royal Bank of Canada stock has been in an unstoppable bull run ...
Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into ...
Finland’s IQM leads Europe’s quantum push with US listing plan
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ...
Why is Arcellx stock up 80% today? Gilead’s $7.8B answer
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday ...
Citrini research: S&P 500 to drop 38% from 2026 highs by June 2028, here’s why
In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” ...
Domino’s tops Q4 US sales estimates on value push, shares rise 5%
Domino’s Pizza reported stronger-than-expected fourth-quarter US same-store sales on Monday, as aggressive ...